{"id":"https://openalex.org/W2887380334","doi":"https://doi.org/10.1158/1538-7445.am2018-838","title":"Abstract 838: Synergistic in vivo activity of the ATR inhibitor BAY 1895344 in combination with the targeted alpha therapy radium-223 dichloride in a preclinical tumor model mimicking bone metastatic castration-resistant prostate cancer (mCRPC)","display_name":"Abstract 838: Synergistic in vivo activity of the ATR inhibitor BAY 1895344 in combination with the targeted alpha therapy radium-223 dichloride in a preclinical tumor model mimicking bone metastatic castration-resistant prostate cancer (mCRPC)","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2887380334","doi":"https://doi.org/10.1158/1538-7445.am2018-838","mag":"2887380334"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-838","doi":"https://doi.org/10.1158/1538-7445.am2018-838","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-838","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064749364","display_name":"Antje Margret Wengner","orcid":"https://orcid.org/0009-0009-5772-1945","observed_orcids":["https://orcid.org/0009-0009-5772-1945"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Antje Margret Wengner","raw_affiliation_strings":["1Bayer AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040107084","display_name":"Gerhard Siemeister","orcid":"https://orcid.org/0000-0002-4712-0531","observed_orcids":["https://orcid.org/0000-0002-4712-0531"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gerhard Siemeister","raw_affiliation_strings":["1Bayer AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112471106","display_name":"Ulrich Luecking","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ulrich Luecking","raw_affiliation_strings":["1Bayer AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045004231","display_name":"Julien Lefranc","orcid":"https://orcid.org/0000-0002-2116-9425","observed_orcids":["https://orcid.org/0000-0002-2116-9425"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Julien Lefranc","raw_affiliation_strings":["1Bayer AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109212479","display_name":"Arne Scholz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Arne Scholz","raw_affiliation_strings":["1Bayer AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034825484","display_name":"Mari I. Suominen","orcid":"https://orcid.org/0000-0002-8760-6595","observed_orcids":["https://orcid.org/0000-0002-8760-6595"]},"institutions":[{"id":"https://openalex.org/I4210124546","display_name":"Pharmatest (Finland)","ror":"https://ror.org/02fkt1r75","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210124546"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Mari Suominen","raw_affiliation_strings":["2Pharmatest Services Ltd., Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Pharmatest Services Ltd., Turku, Finland","institution_ids":["https://openalex.org/I4210124546"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085689791","display_name":"Kirstin Meyer","orcid":"https://orcid.org/0000-0002-2228-2550","observed_orcids":["https://orcid.org/0000-0002-2228-2550"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kirstin Meyer","raw_affiliation_strings":["1Bayer AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073018144","display_name":"Eleni Lagkadinou","orcid":"https://orcid.org/0009-0003-9543-7773","observed_orcids":["https://orcid.org/0009-0003-9543-7773"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Eleni Lagkadinou","raw_affiliation_strings":["1Bayer AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009359386","display_name":"Dominik Mumberg","orcid":"https://orcid.org/0000-0002-6670-1497","observed_orcids":["https://orcid.org/0000-0002-6670-1497"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dominik Mumberg","raw_affiliation_strings":["1Bayer AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"838","last_page":"838"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.7529000043869019,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.7529000043869019,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.07909999787807465,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.03880000114440918,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atr-inhibitors","display_name":"ATR inhibitors","score":0.8840000033378601},{"id":"https://openalex.org/keywords/radium-223-dichloride","display_name":"radium-223 dichloride","score":0.9919999837875366},{"id":"https://openalex.org/keywords/targeted-alpha-therapy","display_name":"targeted alpha therapy","score":0.9919999837875366},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.972000002861023},{"id":"https://openalex.org/keywords/bone-metastases","display_name":"bone metastasis","score":0.9539999961853027},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7089999914169312},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.9440000057220459},{"id":"https://openalex.org/keywords/dna-double-strand-breaks","display_name":"DNA double-strand breaks","score":0.8420000076293945},{"id":"https://openalex.org/keywords/lncap-cells","display_name":"LNCaP cells","score":0.8169999718666077},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.7577805519104004},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6847177743911743},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5595831274986267},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.5507951974868774},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4951898157596588},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4735645055770874},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46771520376205444},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3352656364440918},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.23967194557189941},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.20321756601333618},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1619395911693573},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09763315320014954}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-838","doi":"https://doi.org/10.1158/1538-7445.am2018-838","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-838","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2741677778","https://openalex.org/W3178437799","https://openalex.org/W3127800996","https://openalex.org/W2810588143","https://openalex.org/W2978188039","https://openalex.org/W4394822207","https://openalex.org/W2741851497","https://openalex.org/W2953719394","https://openalex.org/W4414346189","https://openalex.org/W4408701450"],"abstract_inverted_index":{"Abstract":[0],"The":[1,70],"integrity":[2],"of":[3,23,35,39,59,79,102,146,165,179,197,205,235,243,251,285,306,320,333,337,353,419,449],"the":[4,60,108,134,144,202,233,236,260,280,310,351,420,428,450],"genome":[5],"in":[6,30,115,123,217,246,279,309,323,342,385,416,425,434],"eukaryotic":[7],"cells":[8,194],"is":[9,73,133,141,169,293,380],"secured":[10],"by":[11,75,118,303,357,362],"complex":[12],"signalling":[13],"pathways,":[14],"known":[15,158],"collectively":[16],"as":[17,64,94,96,184,239,241,301],"DNA":[18,24,40,53,80,92,120,124,198,253,354],"damage":[19,25,125,254,355],"response":[20],"(DDR).":[21],"Recognition":[22],"activates":[26],"DDR":[27,61,360],"pathways":[28],"resulting":[29],"cell":[31,42,46],"cycle":[32],"arrest,":[33],"suppression":[34],"general":[36],"translation,":[37],"induction":[38,196,356],"repair,":[41],"survival,":[43],"or":[44,127],"even":[45],"death.":[47],"Proteins":[48],"that":[49,172,266,350],"directly":[50],"recognize":[51],"aberrant":[52],"structures":[54],"recruit":[55],"and":[56,68,86,156,214,273,317,391],"activate":[57],"kinases":[58],"pathway,":[62],"such":[63,183],"ATR":[65,71,103,209,421],"(ataxia":[66],"telangiectasia":[67],"Rad3-related).":[69],"kinase":[72,104],"activated":[74],"a":[76,111,170,329,367,435],"broad":[77],"spectrum":[78],"damages,":[81],"including":[82],"double-strand":[83],"breaks":[84],"(DSBs)":[85],"lesions":[87],"derived":[88],"from":[89],"interference":[90],"with":[91,148,208,226,269,299,344,359,375,387,427],"replication":[93,98,128],"well":[95,240],"increased":[97,119],"stress.":[99,129],"Therefore,":[100],"inhibition":[101,361],"activity":[105,278,418],"could":[106],"be":[107],"basis":[109],"for":[110,143,372,453],"novel":[112],"anti-cancer":[113],"therapy":[114,431],"cancers":[116],"characterized":[117],"damage,":[121],"deficiency":[122],"repair":[126],"Radium-223":[130],"dichloride":[131,216,433],"(Xofigo\u00ae)":[132],"first":[135],"approved":[136],"targeted":[137,429],"alpha":[138,430],"therapy.":[139],"It":[140,168],"indicated":[142,302],"treatment":[145,207,268,298,370],"patients":[147,374,386],"castration-resistant":[149,442],"prostate":[150,221,443],"cancer":[151,222,444],"(CRPC),":[152],"symptomatic":[153],"bone":[154,181,185,227,376,440],"metastases":[155],"no":[157],"visceral":[159],"metastatic":[160,441],"disease,":[161],"based":[162],"on":[163,192],"improvement":[164],"overall":[166],"survival.":[167],"calcium-mimetics":[171],"selectively":[173],"binds":[174],"to":[175,258],"hydroxyapatite":[176],"targeting":[177],"areas":[178,319],"high":[180],"turnover":[182],"metastases,":[186],"thereby":[187],"exhibiting":[188],"strong":[189],"cytotoxic":[190],"effects":[191],"adjacent":[193],"via":[195],"DSBs.":[199],"We":[200],"assessed":[201,257],"anti-tumor":[203,277],"efficacy":[204,289],"combination":[206,248,267,343,352,426],"inhibitor":[210,422],"(ATRi)":[211],"BAY":[212,244,271,291,334,364,378,423],"1895344":[213,245,272,292,335,365,379,424],"radium-223":[215,247,274,358,432],"an":[218],"intratibially":[219],"injected":[220],"model":[223,284,438],"mimicking":[224,439],"CRPC":[225,373],"metastases.":[228,377],"In":[229],"vivo":[230,417],"analyses":[231],"addressed":[232],"optimization":[234],"dosing":[237],"schedule":[238],"dose-response":[242],"setting.":[249],"Levels":[250],"intra-tumor":[252],"(P-H2AX)":[255],"were":[256],"demonstrate":[259],"proposed":[261],"mode-of-action.":[262],"Here,":[263],"we":[264],"show":[265],"ATRi":[270,363],"exhibits":[275],"synergistic":[276],"intratibial":[281],"LNCaP":[282],"xenograft":[283],"mCRPC,":[286],"achieving":[287],"best":[288],"when":[290],"applied":[294],"24":[295],"hours":[296],"after":[297],"radium-223,":[300],"direct":[304],"reduction":[305],"tumor":[307,314,437],"burden":[308],"bone,":[311],"lower":[312],"serum":[313],"marker":[315],"(PSA),":[316],"smaller":[318],"tumor-induced":[321],"changes":[322],"bone.":[324],"With":[325],"this":[326],"optimized":[327],"schedule,":[328],"very":[330],"low":[331],"dose":[332],"(3%":[336],"single-agent":[338],"MTD)":[339],"was":[340],"effective":[341],"radium-223.":[345],"Our":[346],"findings":[347],"strongly":[348],"suggest":[349],"creates":[366],"potential":[368],"new":[369],"option":[371],"currently":[381],"under":[382],"clinical":[383],"investigation":[384],"advanced":[388],"solid":[389],"tumors":[390],"lymphomas":[392],"(NCT03188965).":[393],"Citation":[394],"Format:":[395],"Antje":[396],"Margret":[397],"Wengner,":[398],"Gerhard":[399],"Siemeister,":[400],"Ulrich":[401],"Luecking,":[402],"Julien":[403],"Lefranc,":[404],"Arne":[405],"Scholz,":[406],"Mari":[407],"Suominen,":[408],"Kirstin":[409],"Meyer,":[410],"Eleni":[411],"Lagkadinou,":[412],"Dominik":[413],"Mumberg.":[414],"Synergistic":[415],"preclinical":[436],"(mCRPC)":[445],"[abstract].":[446],"In:":[447],"Proceedings":[448],"American":[451],"Association":[452],"Cancer":[454,467],"Research":[455],"Annual":[456],"Meeting":[457],"2018;":[458],"2018":[459],"Apr":[460],"14-18;":[461],"Chicago,":[462],"IL.":[463],"Philadelphia":[464],"(PA):":[465],"AACR;":[466],"Res":[468],"2018;78(13":[469],"Suppl):Abstract":[470],"nr":[471],"838.":[472]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1}],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2018-08-22T00:00:00"}